Mankind Pharma Allots Equity Shares Under ESOP Plan
Mankind Pharma Ltd · Others (Uncategorized) · 01 Sept 2026, 11:29 pm
Mankind Pharma Allots Equity Shares Under ESOP Plan Mankind Pharma announced on 01 Sep'26 the allotment of 49,112 equity shares of ₹1 face value to eligible employees under its ESOP Plan 2022. The exercise price was ₹860.00 per share. Following this allotment, the company's paid-up share capital has increased from 41,29,95,978 shares to 41,30,45,090 shares. The new shares will rank pari-passu with existing equity shares. This issuance represents a minor dilution to existing shareholders.
Original exchange filing (PDF)
More announcements from Mankind Pharma Ltd
- Please find attached intimation regarding change in Corporate Office Address of RTA · 13 Nov 2026
- Please find attached Intimation of participation in the Investor Conference · 06 Nov 2026
- Please find attached intimation regarding ESG Rating · 05 Nov 2026
- Intimation of participation in the Investor Conference. · 03 Nov 2026
- Please find attached transcript of the Earnings Conference Call for Q2 & H1 FY27 · 30 Oct 2026
- Please find attached intimation regarding re-affirmation/withdrawl of Credit Rating by CRISIL · 30 Oct 2026
- In continuation of our earlier intimation dated October 22, 2026 please find attached the Investor Presentation to be made during the said Analyst / Institutional Investors meet · 27 Oct 2026
- Please find attached link for audio recording of the Investor Conference Call held on October 26, 2026 · 27 Oct 2026
